Cellectis Statistics
Total Valuation
Cellectis has a market cap or net worth of EUR 86.22 million. The enterprise value is 33.12 million.
Market Cap | 86.22M |
Enterprise Value | 33.12M |
Important Dates
The last earnings date was Wednesday, March 5, 2025.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cellectis has 72.09 million shares outstanding. The number of shares has increased by 58.85% in one year.
Current Share Class | n/a |
Shares Outstanding | 72.09M |
Shares Change (YoY) | +58.85% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 2.21% |
Owned by Institutions (%) | 17.20% |
Float | 39.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.28 |
PB Ratio | 0.68 |
P/TBV Ratio | 0.69 |
P/FCF Ratio | 4.37 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.93 |
EV / Sales | 0.70 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1.68 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.67.
Current Ratio | 1.73 |
Quick Ratio | 1.00 |
Debt / Equity | 0.67 |
Debt / EBITDA | n/a |
Debt / FCF | 4.33 |
Interest Coverage | -7.99 |
Financial Efficiency
Return on equity (ROE) is -34.08% and return on invested capital (ROIC) is -19.21%.
Return on Equity (ROE) | -34.08% |
Return on Assets (ROA) | -10.37% |
Return on Invested Capital (ROIC) | -19.21% |
Return on Capital Employed (ROCE) | -27.41% |
Revenue Per Employee | 217,072 |
Profits Per Employee | -162,134 |
Employee Count | 222 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.76% in the last 52 weeks. The beta is 3.28, so Cellectis's price volatility has been higher than the market average.
Beta (5Y) | 3.28 |
52-Week Price Change | -50.76% |
50-Day Moving Average | 1.40 |
200-Day Moving Average | 1.72 |
Relative Strength Index (RSI) | 36.08 |
Average Volume (20 Days) | 241,286 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellectis had revenue of EUR 47.54 million and -35.51 million in losses. Loss per share was -0.40.
Revenue | 47.54M |
Gross Profit | 47.54M |
Operating Income | -57.52M |
Pretax Income | -35.51M |
Net Income | -35.51M |
EBITDA | -46.61M |
EBIT | -57.52M |
Loss Per Share | -0.40 |
Balance Sheet
The company has 138.37 million in cash and 85.26 million in debt, giving a net cash position of 53.10 million or 0.74 per share.
Cash & Cash Equivalents | 138.37M |
Total Debt | 85.26M |
Net Cash | 53.10M |
Net Cash Per Share | 0.74 |
Equity (Book Value) | 126.56M |
Book Value Per Share | 1.76 |
Working Capital | 116.68M |
Cash Flow
In the last 12 months, operating cash flow was 22.21 million and capital expenditures -2.49 million, giving a free cash flow of 19.71 million.
Operating Cash Flow | 22.21M |
Capital Expenditures | -2.49M |
Free Cash Flow | 19.71M |
FCF Per Share | 0.27 |
Margins
Gross margin is 100.00%, with operating and profit margins of -121.00% and -74.69%.
Gross Margin | 100.00% |
Operating Margin | -121.00% |
Pretax Margin | -74.69% |
Profit Margin | -74.69% |
EBITDA Margin | -98.04% |
EBIT Margin | -121.00% |
FCF Margin | 41.46% |
Dividends & Yields
Cellectis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.85% |
Shareholder Yield | -58.85% |
Earnings Yield | -41.18% |
FCF Yield | 22.86% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cellectis has an Altman Z-Score of -0.73. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.73 |
Piotroski F-Score | n/a |